Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
METSERA INC
MTSR·59267L107·US·Common Stock·Healthcare - Biotechnology-Activist
MTSR (METSERA INC) is held by 0 institutional investors as of Q4 2025.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold MTSR.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $291,013 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $487,716 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $39,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $225,019 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $261,650 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $34M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $280,646 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $242,340 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $326,016 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $496,821 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $784,950 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $167.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $313,980 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $568,251 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $294,723 | 0.0% | — | 0 |
Showing 1-20 of 98
1 / 5
MTSRMETSERA INCContinue exploring
Other Healthcare stocks held by institutions
LLYEli Lilly & Co.415 holders · $877.5B
UNHUnitedHealth Group Inc.415 holders · $299.1B
TMOThermo Fisher Scientific Inc400 holders · $151.4B
JNJJohnson & Johnson397 holders · $414.1B
DHRDanaher Corporation394 holders · $97.5B
ISRGIntuitive Surgical Inc.393 holders · $111.5B
MRKMerck & Co., Inc390 holders · $230.1B
ABBVAbbVie Inc.385 holders · $302.9B
BSXBoston Scientific Corporation385 holders · $51.8B
ABTAbbott Laboratories382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer